Cellular drug efflux and reversal therapy of cancer

This publication has 24 references indexed in Scilit:

• P‐glycoprotein‐mediated efflux of hydroxyrubicin, a neutral anthracycline derivative, in resistant K562 cells
  FEBS Letters, 1994
• Reversal agent inhibition of the multidrug resistance pump in human leukemic lymphoblasts
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1994
• Inhibition of the multidrug resistance efflux pump
  Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1993
• BIOCHEMISTRY OF MULTIDRUG RESISTANCE MEDIATED BY THE MULTIDRUG TRANSPORTER
  Annual Review of Biochemistry, 1993
• Kinetics of daunorubicin transport by P‐glycoprotein of intact cancer cells
  European Journal of Biochemistry, 1992
• Systemic Toxic Effects Associated With High-Dose Verapamil Infusion and Chemotherapy Administration
  JNCI Journal of the National Cancer Institute, 1991
• Effects of verapamil enantiomers and major metabolites on the cytotoxicity of vincristine and daunomycin in human lymphoma cell lines
  European Journal of Clinical Pharmacology, 1991
• Active outward transport of daunomycin in resistant ehrlich ascites tumor cells
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1973
• Rejection criteria for the asymmetric carrier and their application to glucose transport in the human red blood cell
  Biochimica et Biophysica Acta (BBA) - Biomembranes, 1972
• The pH Dependence of the Competitive Inhibition of Fumarase1,2
  Journal of the American Chemical Society, 1960